-transparent.png){kind=logo}
The clinical effects of cefoxitin (CFX) were studied in 31 cases of respiratory tract infections. The results were as follows: As for the clinical effects, CFX was excellent in 5 cases, good in 13, fair in 8 and poor in 5 out of 31 patients; the efficacy rate was 58.1%. The efficacy rate was 57.1% in bronchopneumonia, 61.1% in pneumonia and 50.0% in acute exacerbation of chronic respiratory tract infections. The efficacy rate was 70.6% in the group of 4 g/day or less and 42.9% in the group of 6 g/day or more. The efficacy rate was 50.0% in 6 cases that had not been responded to other antibiotics previously. As for side effects, skin eruption was observed in only 1 patient. No abnormality was observed in laboratory tests due to CFX. In conclusion, CFX is a useful drug in the treatment of respiratory tract infections.
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
February 1982,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
February 1981,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
January 1984,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
May 1983,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
January 1979,
Reviews of infectious diseases,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
June 1985,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
October 1987,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
July 1978,
The Journal of antimicrobial chemotherapy,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
April 1988,
The Japanese journal of antibiotics,
M Kuwabara, and
Y Kodomari, and
T Jyo, and
T Kuraoka, and
T Mitsuyama, and
N Kodomari, and
K Iwamoto, and
T Miyazawa, and
T Watanabe, and
E Morikawa
November 1986,
The Japanese journal of antibiotics,
